Forgoing healthcare during the COVID-19 pandemic in Geneva, Switzerland - A cross-sectional population-based study.


Journal

Preventive medicine
ISSN: 1096-0260
Titre abrégé: Prev Med
Pays: United States
ID NLM: 0322116

Informations de publication

Date de publication:
03 2022
Historique:
received: 04 10 2021
revised: 17 12 2021
accepted: 06 02 2022
pubmed: 13 2 2022
medline: 4 3 2022
entrez: 12 2 2022
Statut: ppublish

Résumé

Health systems around the world continue to navigate through operational challenges surfaced by the coronavirus disease 2019 (COVID-19) pandemic; these have implications for access to healthcare. In this study, we estimate the prevalence and reasons for forgoing healthcare during the pandemic in Geneva, Switzerland; a country with a universal and mandatory private health insurance coverage. Participants from a randomly selected population-based sample of the adult population living in the Canton of Geneva completed an online socio-demographic and lifestyle questionnaire between November 2020 and January 2021. The prevalence and reasons for forgoing healthcare since the beginning of the COVID-19 pandemic were examined descriptively, and logistic regression models were used to assess determinants for forgoing healthcare. The study included 5397 participants, among which 8.0% reported having forgone healthcare since the beginning of the COVID-19 pandemic; participants with a disadvantaged financial situation (OR = 2.04; 95% CI: 1.56-2.65), and those reporting an average (OR = 2.54; 95% CI: 1.94-3.31) or poor health (OR = 4.40; 95% CI: 2.39-7.67) were more likely to forgo healthcare. The most common reasons to forgo healthcare were appointment cancellations by healthcare providers (53.9%), fear of infection (35.3%), and personal organizational issues (11.1%). Our paper highlights the effects of the COVID-19 pandemic on access to healthcare and identifies population sub-groups at-risk for forgoing healthcare. These results necessitate public health efforts to ensure equitable and accessible healthcare as the COVID-19 pandemic continues.

Sections du résumé

BACKGROUND
Health systems around the world continue to navigate through operational challenges surfaced by the coronavirus disease 2019 (COVID-19) pandemic; these have implications for access to healthcare. In this study, we estimate the prevalence and reasons for forgoing healthcare during the pandemic in Geneva, Switzerland; a country with a universal and mandatory private health insurance coverage.
METHODS
Participants from a randomly selected population-based sample of the adult population living in the Canton of Geneva completed an online socio-demographic and lifestyle questionnaire between November 2020 and January 2021. The prevalence and reasons for forgoing healthcare since the beginning of the COVID-19 pandemic were examined descriptively, and logistic regression models were used to assess determinants for forgoing healthcare.
RESULTS
The study included 5397 participants, among which 8.0% reported having forgone healthcare since the beginning of the COVID-19 pandemic; participants with a disadvantaged financial situation (OR = 2.04; 95% CI: 1.56-2.65), and those reporting an average (OR = 2.54; 95% CI: 1.94-3.31) or poor health (OR = 4.40; 95% CI: 2.39-7.67) were more likely to forgo healthcare. The most common reasons to forgo healthcare were appointment cancellations by healthcare providers (53.9%), fear of infection (35.3%), and personal organizational issues (11.1%).
CONCLUSION
Our paper highlights the effects of the COVID-19 pandemic on access to healthcare and identifies population sub-groups at-risk for forgoing healthcare. These results necessitate public health efforts to ensure equitable and accessible healthcare as the COVID-19 pandemic continues.

Identifiants

pubmed: 35150752
pii: S0091-7435(22)00035-4
doi: 10.1016/j.ypmed.2022.106987
pmc: PMC8828292
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

106987

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Références

Can J Public Health. 2006 May-Jun;97 Suppl 2:S26-30
pubmed: 16805158
BMC Oral Health. 2014 Sep 30;14:121
pubmed: 25270828
Eur J Cancer. 2021 Jul;152:233-242
pubmed: 34049776
Am J Med Qual. 2011 Jul-Aug;26(4):261-71
pubmed: 21478458
Prev Med. 2021 Sep;150:106696
pubmed: 34174252
Prev Med. 2012 Nov;55(5):521-7
pubmed: 22940614
BMJ Open. 2022 Jan 31;12(1):e055515
pubmed: 35105645
JAMA. 2020 Oct 20;324(15):1562-1564
pubmed: 33044483
Allergy. 2021 Feb;76(2):428-455
pubmed: 33185910
Psychol Health Med. 2021 Jan;26(1):35-43
pubmed: 32490689
Vaccine X. 2021 Aug;8:100094
pubmed: 33821245
Lancet Infect Dis. 2021 May;21(5):600-601
pubmed: 33539733
Braz J Psychiatry. 2020;42(3):232-235
pubmed: 32267343
JAMA Netw Open. 2021 Jan 4;4(1):e2034882
pubmed: 33475757
Lancet. 2020 Aug 1;396(10247):313-319
pubmed: 32534626
Eur J Emerg Med. 2020 Aug;27(4):233-234
pubmed: 32345850
JAMA. 2018 Mar 13;319(10):1024-1039
pubmed: 29536101
Eur J Ageing. 2021 Jun 11;19(4):793-809
pubmed: 34149338
Swiss Med Wkly. 2020 May 04;150:w20284
pubmed: 32400882
PLoS One. 2021 Jul 29;16(7):e0254989
pubmed: 34324533
Front Sociol. 2021 Jun 08;6:648395
pubmed: 34169112

Auteurs

Lakshmi Krishna Menon (LK)

Unit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals, Rue Jean-Violette 29, 1205 Genève, Switzerland; Institute of Global Health, University of Geneva, Chemin des Mines 9, 1202 Genève, Switzerland. Electronic address: lakshmi.menon@etu.unige.ch.

Viviane Richard (V)

Unit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals, Rue Jean-Violette 29, 1205 Genève, Switzerland. Electronic address: vivianeadissa.richard@hcuge.ch.

Carlos de Mestral (C)

Unit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals, Rue Jean-Violette 29, 1205 Genève, Switzerland. Electronic address: carlos.demestral@hcuge.ch.

Hélène Baysson (H)

Unit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals, Rue Jean-Violette 29, 1205 Genève, Switzerland; Department of Health and Community Medicine, Faculty of Medicine, University of Geneva, Rue Michel-Servet 1, 1211 Genève, Switzerland. Electronic address: helene.baysson@unige.ch.

Ania Wisniak (A)

Unit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals, Rue Jean-Violette 29, 1205 Genève, Switzerland; Institute of Global Health, University of Geneva, Chemin des Mines 9, 1202 Genève, Switzerland. Electronic address: ania.wisniak@hcuge.ch.

Idris Guessous (I)

Department of Health and Community Medicine, Faculty of Medicine, University of Geneva, Rue Michel-Servet 1, 1211 Genève, Switzerland; Division of Primary Care Medicine, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 4, 1205 Genève, Switzerland. Electronic address: idris.guessous@hcuge.ch.

Silvia Stringhini (S)

Unit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals, Rue Jean-Violette 29, 1205 Genève, Switzerland; Division of Primary Care Medicine, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 4, 1205 Genève, Switzerland; University Center for General Medicine and Public Health, University of Lausanne, Rue du Bugnon 44, 1011 Lausanne, Switzerland. Electronic address: silvia.stringhini@hcuge.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH